Concise review: Generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversion

Stem Cells

Volumn 32, Issue 11, 2014, Pages 2811-2817

  Velasco, Iván ^a,b   Salazar, Patricia ^a,b   Giorgetti, Alessandra ^c   Ramos Mejía, Verõnica ^b   Castaño, Julio ^c   Romero Moya, Damià ^c   Menendez, Pablo ^c,d  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b PTS Granada   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Direct conversion; Genome editing; Induced neurons; Induced pluripotent stem cells; Neural differentiation; Neurodegenerative diseases

Indexed keywords

ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; FIBROBLAST; GENETIC ENGINEERING; GENETICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; METABOLISM; NERVE CELL; NUCLEAR REPROGRAMMING; PHYSIOLOGY; PROCEDURES;

ANIMALS; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; FIBROBLASTS; GENETIC ENGINEERING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEURONS;

EID: 84907898022     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1782     Document Type: Review

References (70)

1. Martin GR,. Teratocarcinomas and mammalian embryogenesis. Science 1980; 209: 768-776.
2. Shamblott MJ, Axelman J, Wang S, et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 1998; 95: 13726-13731.
3. Evans MJ, Kaufman MH,. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292: 154-156.
4. Martin GR,. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981; 78: 7634-7638.
5. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
6. Ludolph DC, Neff AW, Mescher AL, et al. Overexpression of XMyoD or XMyf5 in Xenopus embryos induces the formation of enlarged myotomes through recruitment of cells of nonsomitic lineage. Dev Biol 1994; 166: 18-33.
7. Yutzey KE, Rhodes SJ, Konieczny SF,. Differential trans activation associated with the muscle regulatory factors MyoD1, myogenin, and MRF4. Mol Cell Biol 1990; 10: 3934-3944.
8. Graf T, Enver T,. Forcing cells to change lineages. Nature 2009; 462: 587-594.
9. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
10. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
11. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-1920.
12. Malik N, Rao MS,. A review of the methods for human iPSC derivation. Methods Mol Biol 2013; 997: 23-33.
13. Ramos-Mejia V, Montes R, Bueno C, et al. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors. PLoS One 2012; 7: e35824.
14. Ramos-Mejia V, Munoz-Lopez M, Garcia-Perez JL, et al. iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability. Cell Res 2010; 20: 1092-1095.
15. Nakanishi M, Otsu M,. Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine. Curr Gene Ther 2012; 12: 410-416.
16. Schott JW, Galla M, Godinho T, et al. Viral and non-viral approaches for transient delivery of mRNA and proteins. Curr Gene Ther 2011; 11: 382-398.
17. Okita K, Nakagawa M, Hyenjong H, et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949-953.
18. Lorenzo IM, Fleischer A, Bachiller D,. Generation of mouse and human induced pluripotent stem cells (iPSC) from primary somatic cells. Stem Cell Rev 2013; 9: 435-450.
19. Anokye-Danso F, Trivedi CM, Juhr D, et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011; 8: 376-388.
20. Miyoshi N, Ishii H, Nagano H, et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 2011; 8: 633-638.
21. Barroso-del Jesus A, Lucena-Aguilar G, Menendez P,. The miR-302-367 cluster as a potential stemness regulator in ESCs. Cell Cycle 2009; 8: 394-398.
22. Barroso-delJesus A, Lucena-Aguilar G, Sanchez L, et al. The Nodal inhibitor Lefty is negatively modulated by the microRNA miR-302 in human embryonic stem cells. FASEB J 2011; 25: 1497-1508.
23. Barroso-delJesus A, Romero-Lopez C, Lucena-Aguilar G, et al. Embryonic stem cell-specific miR302-367 cluster: Human gene structure and functional characterization of its core promoter. Mol Cell Biol 2008; 28: 6609-6619.
24. Card DA, Hebbar PB, Li L, et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 2008; 28: 6426-6438.
25. Rosa A, Brivanlou AH,. A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation. EMBO J 2011; 30: 237-248.
26. Onder TT, Kara N, Cherry A, et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 2012; 483: 598-602.
27. Gore A, Li Z, Fung HL, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011; 471: 63-67.
28. Hussein SM, Batada NN, Vuoristo S, et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011; 471: 58-62.
29. Pasi CE, Dereli-Oz A, Negrini S, et al. Genomic instability in induced stem cells. Cell Death Differ 2011; 18: 745-753.
30. Hanna JH, Saha K, Jaenisch R,. Pluripotency and cellular reprogramming: Facts, hypotheses, unresolved issues. Cell 2010; 143: 508-525.
31. Hong H, Takahashi K, Ichisaka T, et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009; 460: 1132-1135.
32. Kawamura T, Suzuki J, Wang YV, et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009; 460: 1140-1144.
33. Marion RM, Strati K, Li H, et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009; 460: 1149-1153.
34. Rais Y, Zviran A, Geula S, et al. Deterministic direct reprogramming of somatic cells to pluripotency. Nature 2013; 502: 65-70.
35. Guo S, Zi X, Schulz VP, et al. Nonstochastic reprogramming from a privileged somatic cell state. Cell 2014; 156: 649-662.
36. Amoroso MW, Croft GF, Williams DJ, et al. Accelerated high-yield generation of limb-innervating motor neurons from human stem cells. J Neurosci 2013; 33: 574-586.
37. Erceg S, Ronaghi M, Zipancic I, et al. Efficient differentiation of human embryonic stem cells into functional cerebellar-like cells. Stem Cells Dev 2010; 19: 1745-1756.
38. Jaeger I, Arber C, Risner-Janiczek JR, et al. Temporally controlled modulation of FGF/ERK signaling directs midbrain dopaminergic neural progenitor fate in mouse and human pluripotent stem cells. Development 2011; 138: 4363-4374.
39. Kriks S, Shim JW, Piao J, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011; 480: 547-551.
40. Maroof AM, Keros S, Tyson JA, et al. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 2013; 12: 559-572.
41. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321: 1218-1221.
42. Lopez-Gonzalez R, Velasco I,. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells. Arch Med Res 2012; 43: 1-10.
43. Corti S, Nizzardo M, Simone C, et al. Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Sci Transl Med 2012; 4: 165ra162.
44. Ebert AD, Yu J, Rose FF, Jr,. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277-280.
45. Sanchez-Danes A, Richaud-Patin Y, Carballo-Carbajal I, et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol Med 2012; 4: 380-395.
46. Soldner F, Laganiere J, Cheng AW, et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 2011; 146: 318-331.
47. Israel MA, Yuan SH, Bardy C, et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012; 482: 216-220.
48. Marchetto MC, Carromeu C, Acab A, et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010; 143: 527-539.
49. Cooper O, Seo H, Andrabi S, et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med 2012; 4: 141ra190.
50. Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell 2008; 134: 877-886.
51. Wray S, Self M, Consortium NPsDi et al. Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLoS One 2012; 7: e43099.
52. Zhang Y, Pak C, Han Y, et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 2013; 78: 785-798.
53. Pang ZP, Yang N, Vierbuchen T, et al. Induction of human neuronal cells by defined transcription factors. Nature 2011; 476: 220-223.
54. Vierbuchen T, Ostermeier A, Pang ZP, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010; 463: 1035-1041.
55. Caiazzo M, Dell'Anno MT, Dvoretskova E, et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 2011; 476: 224-227.
56. Pfisterer U, Kirkeby A, Torper O, et al. Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci USA 2011; 108: 10343-10348.
57. Son EY, Ichida JK, Wainger BJ, et al. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell 2011; 9: 205-218.
58. Ring KL, Tong LM, Balestra ME, et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 2012; 11: 100-109.
59. Giorgetti A, Marchetto MC, Li M, et al. Cord blood-derived neuronal cells by ectopic expression of Sox2 and c-Myc. Proc Natl Acad Sci USA 2012; 109: 12556-12561.
60. Lu J, Liu H, Huang CT, et al. Generation of integration-free and region-specific neural progenitors from primate fibroblasts. Cell Rep 2013; 3: 1580-1591.
61. Ban H, Nishishita N, Fusaki N, et al. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci USA 2011; 108: 14234-14239.
62. Merling RK, Sweeney CL, Choi U, et al. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells. Blood 2013; 121: e98-107.
63. Torper O, Pfisterer U, Wolf DA, et al. Generation of induced neurons via direct conversion in vivo. Proc Natl Acad Sci USA 2013; 110: 7038-7043.
64. Guo Z, Zhang L, Wu Z, et al. In Vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model. Cell Stem Cell 2014; 14: 188-202.
65. Simara P, Motl JA, Kaufman DS,. Pluripotent stem cells and gene therapy. Transl Res 2013; 161: 284-292.
66. Li M, Suzuki K, Kim NY, et al. A cut above the rest: Targeted genome editing technologies in human pluripotent stem cells. J Biol Chem 2014; 289: 4594-4599.
67. Shen B, Zhang W, Zhang J, et al. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat Methods 2014; 11: 399-402.
68. Wu Y, Gao T, Wang X, et al. TALE nickase mediates high efficient targeted transgene integration at the human multi-copy ribosomal DNA locus. Biochem Biophys Res Commun 2014; 446: 261-266.
69. An MC, Zhang N, Scott G, et al. Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells. Cell Stem Cell 2012; 11: 253-263.
70. Liu GH, Qu J, Suzuki K, et al. Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. Nature 2012; 491: 603-607.